chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 36 year old female nurse with asthma and drug allergies who in August 2002, was vaccinated with a first dose of varicella virus vaccine live.  It was reported that she did not receive a second dose.  A titer was drawn and the patient failed to seroconvert.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. Pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 04-MAY-2015, the patient was vaccinated with second dose of improperly stored GARDASIL, lot # K008931, expiry date 02-NOV-2016, 0.5 milliliter (ml), intramuscularly, that was exposed to 31.1F for 30 hours. No adverse effect was reported. The outcome of events was unknown. No product quality complaint (PQC) was involved. No further information was provided. Additional information has been requested.
Fever, headache, body aches, sharp lower back pain, redness in lower legs (from knee down) - the way a sunburn would appear, loss of sensation on lower legs for a couple of hours.  This all happened within 24 hours of receiving the vaccine.
Left arm is swollen, red, and painful. Treatment was to be monitored and to be treated if worsen.
Knot, cherry-sized, swelling that lasted 3 months. Swelling in arm and bruise for 2 months after 2nd shot on 2/23/1999. Flu-like symptoms and headache, 2 weeks after 3rd shot, lasted 2 days and reportedly same 3 weeks later, shot given on 10/20/1999.
Patient received Moderna #1 on 3/18/2021 at Hospital.  The next day he developed a rash on his face and chest that was not itchy or painful.  It lasted less than 24 hours.  Then developed dizziness and vertigo for 3-4 days, episodes lasted a few seconds and noted that it happened more when looking at screens, had the sensation of spinning and a feeling like he may fall over.  He has also complained of bilateral ear ringing and a dull pain in his left ear.
Patient began uncontrollable crying. Patient could not be consoled at any measures parents took. Crying spell was reported to last about 3 hours.
Soreness of shot area, hoarseness, sore swollen throat, red itchy eyes, cough, aches, headache (I worn sunglasses because light made it worse), fatigue, runny and congested nose. First reaction I have had to a vaccine.
Information has been received from a pharmacist concerning a patient who on 27-Jul-2008 was vaccinated with PNEUMOVAX 23 (lot# 662042/0622X) (route, site of administration not reported). The patient experienced injection site reaction after receiving the vaccine on the same day. The injection site became red and swollen. The patient sought unspecified  medical attention. The patient was recovering. This is one of several reports from the same source. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the evaluation and research and was released. Additional information has been requested.
After the 2nd vaccine, this patient had joint and muscle pain, generalized muscle spasms, onset of illness 12/00. Pain medication, anti-anxiety, depressants, and sleeping medication given.
doses administered past the published expiry date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.
Client received vaccine at 9:15 am. Waited more than 15 mins. At 9:50 client says she saw her arm in the mirror in the restroom and wanted to show me. Client had redness, about 2" circle and swelling around vaccine site. Advised ice to the site. Advised to watch for continued swelling, rash or difficulty breathing, and if these occur to seek medical attention.
palpitations; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Jun-2021 and was forwarded to Moderna on 01-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included Premature ventricular contractions.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (palpitations). At the time of the report, PALPITATIONS (palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and Concomitant medicines were not provided  Action taken with mRNA-1273 in response to the event was unknown
Pt. came to pharmacy 10/21/17 and said her back had a rash on both sides and was very itchy. She stated that she woke up sweating and believes she has a slight fever. She was using hydrocortisone cream on rash. I recommended BENADRYL tabs at night and the cream during the day and to follow up w/PCP.
This case was reported by a nurse and described the occurrence of a positive pertussis identification test in an infant subject gender unknown who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix) for prophylaxis. At an unspecified time, the subject received a dose of Pediarix (lot number unknown). At an unspecified time after vaccination with Pediarix, the subject had a pertussis identification test that was positive. The nurse stated that the physician did not think the case was related to Pediarix. She stated that she called to "find out if Pediarix could cause a false positive on the polymerase chain reaction (PCR) for pertussis". The outcome of the events was not reported.
Hard to breathe as throat swelled up so much it was hard to get air inhaled and exhaled. Numbness in left arm and chest. It resembled a heart attack. Extreme muscle, joint and nerve pain. Has had the intense muscle, joint and nerve pain constantly after the flu shot.
A patient received an expired 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient received an expired 1st dose) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient received an expired 1st dose). On 19-Oct-2021, EXPIRED PRODUCT ADMINISTERED (A patient received an expired 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was also reported that the vial did not undergo any temperature excursions  Concomitant medication information was not reported  Treatment information was not reported
Injection site reaction, pain, tenderness, swelling , hard lump, hot to touch, redness, itching. Day after injection the site was red hard lump the size of a walnut hot to touch.  Swelling got larger on day 3 and 4 to the size of a baseball. On day 5 it grew to the size of a softball, redness went down still tender, warm to touch itching and painful arm.
Approximately 3 to 4 minutes after receiving my first vaccine, I had a hot feeling travel from my toes up to my head. I then became dizzy and felt very faint. The tip of my tongue also became numb. I was too embarrassed to alert the hospital worker.  The sensation lasted about a minute. However, the last 2 1/2 days I have been having a fast heart rate after doing  minimal activities. I feel very winded by the slightest task. I did go to a clinic today to get my vitals checked. They were fine- but I still continue to feel like my heart rate spikes when I do something as minimal as emptying the dishwasher. It?s very scary and uncomfortable and makes me fearful of taking the second shot.
Started experiencing slight numbness, tingling, and pins and needle sensations up and down my left arm from the shoulder to my hand within a hour after my second dose.; Tingling and pins and needle sensations up and down my left arm from the shoulder to my hand within a hour after my second dose; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the right arm on 01Oct2021 at 09:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the right arm on 10Sep2021 at 09:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. On 01Oct2021 at 10:30, within an hour after second dose of vaccination, the patient experienced slight numbness, tingling, pins and needle sensations up and down the left arm from the shoulder to hand. This had been a generally consistent sensation since then and comes and goes throughout the day and night. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slight numbness, tingling, pins and needle sensations up and down the left arm from the shoulder to hand were not resolved at the time of this report.
Had miscarriage that started April 2, 2021 at around 11pm. It started 2 weeks after 1st does of vaccine was administered. This was my 2nd pregnancy that resulted in a miscarriage. Previous miscarriage was in Sept. 2020. Was about 6 weeks pregnant for both miscarriages with the latest one with a projected Nov. 24, 2021 Due Date.
No symptoms or treatment needed. Physician contacted mother as this was found after the patient left the office. Mother was informed to watch patient for any symptoms or side effects and to call with any concerns.
This spontaneous report as received from a nurse of unknown age refers to herself. The nurse stated that she had received ZOSTAVAX twice. She was administered with the first dose of ZOSTAVAX on 17-JUN-2008 (dose, route and lot # unknown) and the second dose on 26-SEP-2014 (dose, route and lot # unknown). No adverse effect was reported. Additional information has been requested.
Developed pleurisy.  Shortness of breath, chest pain radiating into shoulders (predominantly the left shoulder).  Presented to doctor's office, did lab work, did chest x-ray, did CT, did echo, followed up with cardiologist new patient consultant and received diagnosis of pleurisy.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. It was reported thought that the vaccine expired in Jun 2022, however it was expired on 01 Apr 2022. Date the vial was initially stored in refrigerator was 04 Apr 2022. Vial had not undergone any temperature excursion. No treatment information was reported.
Returned to clinic complaining dizziness and lightheadedness. BP 134/76 P-74 irreg - At 1115 AM BP 110/70 - 120 irregular. Had a few red blotches on neck & face was flushed. BP remained good - AP remained between 120 & 100 Transferred to hospital. Pt received BENADRYL & CORTISONE. Heart rate remained elevated - was normal on 11-14-09 & pt was discharged 11/23/2009 ED records for 11/13/2009, patient presents with c/o's dizziness, hives, itchy rash. IV Solumedrol and Zantac. Was tacchycardic which resolved.
I have history of drug reaction to Clindamycin (true allergy) and to Levofloxacin (rash, may not have been true allergy). After the second dose I had itchy rash all over my body, sparing face, hands and feet, Resembles the drug rashes in appearance, distribution and itchiness. It hasn't gotten much better. It does seem to be bad in my upper left arm, and not on the upper right arm. Antihistamines and triamcinolone ointment havent really settled it down.
13 May - Pt called back saying that last night she developed R side facial numbness including right half of tongue with blurred vision, denied facial droop, muscle weakness. Pt took a benadryl last night fell asleep and in the morning sxs resolved. However, pt states she is starting to feel sxs return, lip is turning red, feeling numbness/tingling on face. Denies light sensitivity and pupil is reacting appropriately to light per pt. Patient described distribution of trigeminal nerve all branches and ophthalmic nerve. 20 May - all symptoms resolved expect right eye visual disturbance described as "haziness". Exam including CN2-12, lymph and visual acuity all normal.
Painful injection site (hard to move) Fever & chills (100.5F) around the clock  Muscle aches & weakness  Urinary urgency/frequent urination even when bladder just emptied
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about11-SEP-2012, the patient was inoculated with ZOSTAVAX by a healthcare provider to obtain permanent prevention and protection against shingles and zoster-related injuries (dose, route, and lot # not provided).On an unknown date, the patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of patient's injuries. The patient was treated by a healthcare provider for shingles on or about 31-JAN- 2016. The lawyer reported that as a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death- aggravation of preexisting conditions and activation- of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. By the time of the report, the patient did not recover from shingles as the patient suffer for ongoing injuries. The outcome of vaccination failure was unknown. The events were considered to be related to ZOSTAVAX.
The vial was initially stored in the refrigerator 25Feb2022 and  date administered on 30 Mar 2022; doses administered after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and  date administered on 30 Mar 2022) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L21A) for COVID-19 vaccination.     Patient had no known drug allergies and no acute/ chronic illnesses.   On 30-Mar-2022 at 8:47 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2022 at 8:47 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and  date administered on 30 Mar 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator 25Feb2022 and  date administered on 30 Mar 2022) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative (Negative) Patient had No Covid-19 within last month..  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  Dose administered after 30 day use by date or after manufacturer date of expiry. Number of doses or vials administered 36 doses. Date and time the vial was initially stored in the refrigerator 25-Feb-2022. Date and time of administration of vaccine was 01-Apr-2022 and 08-Apr-2022. The vial had not undergone any temperature excursion.  No treatment medications were reported
Patient received her first dose of Pfizer COVID.   Lot # EN2600 Site: RD Patient started to develop swelling to her right shoulder at the injection site where she had a COVID-19 vaccinate. Patient was referred by the vaccinator staff to go to the ER for evaluation.   During the examination, patient denied any itching, redness, or new rash. Patient also denied any sensation of tongue, throat, or neck swelling. Patient also denied SOB or palpitation during visit. She denied history of allergy to eggs. For the swelling at the injection area, she said it was mildly sore but not particularly painful.
Approximately 5 pm i started feeding my daughter. I was holding her sideline like i was showed in the hospital. After about a few mins of her beggining her feed she started choking and spitting milk out of her nose and mouth. She turned purple from head to toe and stop breathing for approximately 30 seconds we rubbed her back to get her to breathe and called 911 when they arrived eveerything sounded good and looked good. Prior to this incident she has never had any problems no acid reflux or any kind of health problems other then being born 3 months early
I had a fever for four days, starting within a few hours of receiving the vaccine. Aches. Extreme pain in my tonsils, accompanied by white cultures. Body aches and chills. Congestion. Post nasal drip. As of 6 days later, I am still having low-grade fever and tonsil cultures, accompanied by severe sore throat. I have all the symptoms of tonsillitis.
This spontaneous report has been received from a nurse referring to a 21 month old male patient. The patient's medical history, concurrent conditions or concomitant medication were not reported. On 22-MAR-2017, the patient was vaccinated with an expired dose of M-M-R II (which had the lot number reported as L0939213, expiration date 17-MAR-2017) (dosage information, route or anatomical site of vaccination were not informed) for prophylaxis. No adverse effects were noted. And there was no product quality complaint involved. This is one of two cases from the same reporter. Additional information is not expected, since the physician cannot be contacted.; Sender's Comments:  US-009507513-1703USA011956:
COVID ARM; RED, SWOLLEN, WARM TO THE TOUCH; LASTED 4 DAYS; PUT ICE ON IT, AND IT HAS GONE DOWN SIGNIFICANTLY
Information has been received from a physician concerning a female pt in her forties who in the past was vaccinated with a dose of varicella virus vaccine live. On 27Feb2004, it was reported that the pt was recently exposed to varicella and her titer is now 0.85. Unspecified medical attention was sought. There was no product quality complaint involved. No further information is available at this time. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a 61 years old female patient. The patient's medical history included hyperparathyroidism and drug reactions/allergies to terramycin (not further specified). On 11-JAN-2013 the patient was vaccinated subcutaneously with ZOSTAVAX from a pharmacy (dose number lot number, dose not reported). No other co-suspects were reported. The patient was concomitantly using unspecified thyroid medications. On 12-JAN-2013 the patient experienced itching at the injection site. On 13-JAN-2013 the patient experienced a lump and erythema below the injection site. The affected area was about 5 inches. The patient received a moist compress as treatment. On 14-JAN-2013 the lump was decreasing in size. No relevant tests were performed and the patient did not seek medical attention. The outcome of the events was reported as recovering/resolving. A reporter causality for itching at the injection site, and for lump and erythema below the injection site was not reported for ZOSTAVAX. Additional information has been requested.
After two days I start itching profusely with red bumps all over my body. This lasted for 10 days after the start
Nausea, Vomiting, Dizziness, Hypertension, fatigue. IV Fluids were given.  Patient  signed form to be released home after fluids she reported symptoms improved.
It's not clear on the documentation if it's Fe3590 or Fe3570. Symptoms started with when I walked, I couldn't keep my back upright. It felt as if my abdomen muscles weren't working. Then I noticed shortness of breath after any activity. Then I felt as if my legs weren't attached to my body. It takes great control to use my muscles to walk.
inflammation of the heart; This is a spontaneous report received from a non-contactable consumer (patient's sister). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose (dose number unknown) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced inflammation of the heart on an unspecified date with outcome of unknown. The patient was in the hospital after taking the COVID vaccine. He has inflammation of the heart. He didn't have any issues prior to the vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.